John Lukaszczyk, MD
Surgery · Fountain Hill, PANPI 1528053873
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.2% of the total across 18 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Smith+Nephew at 35.8% of the total. Reporting peaked in 2024 at $132 and has fallen 58.4% since, to $55 in 2025. That places this record below the midpoint for surgery clinicians in PA, where the typical reported total is $1,143.
Across 18 payments — averaging $23.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$153
- Medtronic$74
- Boston Scientific$41
- CSL Behring$35
- Applied Medical Resources Corporation$33
- Z-medica, LLC$25
- plus $67 from 4 others
What the payments were for
- Consulting fees$256%
- Food & beverage$40394%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 8 | $153 |
| Medtronic | 2 | $74 |
| Boston Scientific | 1 | $41 |
| CSL Behring | 1 | $35 |
| Applied Medical Resources Corporation | 1 | $33 |
| Z-medica, LLC | 1 | $25 |
| TELA Bio, Inc. | 1 | $19 |
| KCI USA, Inc. | 1 | $18 |
| Endo Pharmaceuticals Inc. | 1 | $15 |
| Davol Inc. | 1 | $15 |
How this compares
$428 in reported general payments places this provider in the 30th percentile of 1,424 surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 56 | $117 |
| Tamsulosin Hcl | 12 | $51 |
Paid to pharmacies, not to this prescriber.
Other surgery in Fountain Hill
- Andy KiserPittsburgh$1M
- Glenn SteeleDanville$698K
- Maher El ChaarAllentown$667K
- George EidPittsburgh$619K
- Paul CesanekAllentown$469K
- Clark GerhartPlains$317K
- Irina YermilovPlymouth Meeting$315K
- Eric PauliHershey$202K
- Ariel AballayPittsburgh$198K
- Ann RogersHershey$198K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.